EN

Translate:

What We Do

Pharma Grade Hyaluronan

Hyaluronan with Mw of 7 to 2300 KDa

  

  • Source: bacterial fermentation (Streptococcus equi, subsp. zooepidemicus), non haemolytic and no animal derived materials used during production


  • Toxicology: toxicity data available upon request (under CDA)


  • Quality:
    • Ph. Eur. latest addition
    • US Phamacopeia Pending Monograph
    • ISO 9001: 2008
    • GMP facility according to ICH Q7
    • In-house quality management


  • Certificates and Registrations:
    • GMP certificate - State Institute for Drug Control, Prague, Czech Republic
    • CEP certificates (Certificates of Suitability fo the Ph. Eur.) from EDQM, France
    • DMF with the US FDA
    • DMF with the European ASMF
    • US FDA audited facility


  • Storage and Stability:
    • The stability and quality of hyaluronan powder is guaranteed for 36 months when stored in originally sealed packaging at a temperature of 2–8 °C.
    • Hyaluronan is packaged under strict guidelines and is delivered in a polyethylene bag and three-layer aluminium foil pouch.
    • Packaging size is based upon customer's demand.


  • MW range from small oligosaccharides to industrial material from 7 to 2300 kDa with a tight dispersity of +/- 100 kDa, thus delivering a very targeted Mw


  • Hyaluronan Forms 
    • Fine powder as an API
    • HA based derivate technologies
    • Drug delivery applications
    • Microfibers
    • Nanofibers


Custom Hyaluronan available upon request

Hyaluronan Formulations and Support

Custom Hyaluronan Formulations

TAK Biopharma can develop proprietary custom formulations based on hyaluronan for many application areas including cosmetics, medical devices and pharmaceuticals.


We have extensive experience working with medical device and pharmaceutical clients developing viscous formulations in the areas of dermo cosmetics (topical and injectable), dermal fillers, mesotherapy, wound care, ophthalmology, orthopaedics and oncology.


We can also support in the area of drug delivery and controlled release.


Formulation Support

TAK Biopharma can support and help with existing client formulations either in optimising those formulations for better processability, sterilisation and/or effectiveness in the determined application area.


We can support in the following areas:


  • Chemical characteristics
  • Swelling properties
  • Viscoelastic properties
  • Injectability
  • Heat stability
  • General Formulation properties
  • Bio stability

Contact Us

Have Questions?

Feel free to reach out and get in touch.

TAK Biopharma, IVS

Copenhagen Bio Science Park, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark

+45 25 21 80 64 or +45 53 52 00 44

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel